| abstract |
There is provided compounds of formula I, n n n n n n n n n n wherein Y, ring A, D 1 , D 2a , D 2b , D 3 , L 1 , Y 1 , L 2 and Y 2 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C 4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation. |